LabCompass

Attaya Suvannasankha

Medicine · Indiana University

Publications

198

Citations

3,755

Est. group size

Recurring co-author estimate

Active years

29

Publishing since 1998

Research summary
AI-generated

This researcher focuses on multiple myeloma, a cancer of the plasma cells in the bone marrow, with an emphasis on developing and testing new treatments. Much of the work involves clinical trials of immunotherapies, including bispecific antibodies and CAR T-cell therapy, that harness the immune system to fight the disease in patients whose cancer has returned or resisted prior treatment. Additional work covers treatment guidelines, cost-effectiveness of therapies, and disparities in access to care.

Multiple myeloma treatmentCancer immunotherapy (antibodies, CAR T-cells)Clinical trials for relapsed/refractory diseaseTreatment guidelines and cost-effectivenessAccess to care and health disparities

Publication activity has grown substantially over the past decade, with a notable surge in recent years (37 in 2023 and 46 in 2025).

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 21.8/year recently
2017: 7 publications172018: 3 publications182019: 1 publication192020: 10 publications202021: 4 publications212022: 11 publications222023: 37 publications232024: 12 publications242025: 46 publications46252026: 3 publications26
Recent publications
Publishes in
  • Blood×34
  • Clinical Lymphoma Myeloma & Leukemia×14
  • Journal of Clinical Oncology×11
  • Cancer Research×5
  • HemaSphere×4

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile